SAB Biotherapeutics SABS
NASDAQ SABS
$3.11 +0.04 (+1.30%)
At close: Nov 11, 2026 · 4:00 PM EST

SAB Biotherapeutics (SABS) Accumulated Expenses (2020 - 2026)

Updated

SAB Biotherapeutics (SABS) recorded Accumulated Expenses of $1.1 million in Q3 2023, unchanged from the prior quarter.

Analysis

SAB Biotherapeutics (SABS) Accumulated Expenses (2020 - 2026) Analysis & Trends

At the end of FY2020, SAB Biotherapeutics reported Accumulated Expenses of $156,201.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 SAB Biotherapeutics 279.79 Mn -130.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21,000.00
Mar 31, 2026 20,835.00
Dec 31, 2025 21,000.00
Sep 30, 2025 21,311.00
Jun 30, 2025 21,542.00
Mar 31, 2025 21,997.00
Dec 31, 2024 22,443.00
Sep 30, 2024 22,211.00
Jun 30, 2024 98,383.00
Mar 31, 2024 88,203.00
Dec 31, 2023 77,995.00
Sep 30, 2023 66,375.00
Jun 30, 2023 55,875.00
Mar 31, 2023 22,265.00
Dec 31, 2022 8,192.00
Sep 30, 2022 -2.22 Mn
Jun 30, 2022 -2.60 Mn
Mar 31, 2022 -599,105.00
Sep 30, 2021 322,376.00
Jun 30, 2021 152,879.00
API Access

SAB Biotherapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=SABS&period=max&api_key=YOUR_API_KEY